ghk-cu peptide clinical research GHK-CU – Research Peptide |

Our framework emphasizes biomarker-informed assessment to help patients and providers identify who may benefit most from peptide-based strategies

Ready to talk about whether BPC-157 is right for you

Studies show that vitamin B12 levels require careful monitoring during treatment, as documented changes in B12 absorption can occur over time

doi: 10.1186/s12889-019-7002-z 254

& Marcos, V

For patients without neurological involvement , hydroxocobalamin 1 mg is administered intramuscularly three times a week for 2 weeks, followed by maintenance injections every three months for life (if due to pernicious anaemia or other non-dietary cause)